Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2014
07/24/2014WO2014113792A1 Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation
07/24/2014WO2014113723A1 Methods for diagnosing and treating sepsis
07/24/2014WO2014113648A1 Crystallized oxalate decarboxylase and methods of use
07/24/2014WO2014113641A1 Selective glycosidase regimen for immune programming and treatment of cancer
07/24/2014WO2014113450A1 Decreasing inflammatory response in a blood vessel
07/24/2014WO2014113439A1 Methods for mobilizing hematopoietic stem cells
07/24/2014WO2014113434A1 Therapeutic agents, compositions, and methods for glycemic control
07/24/2014WO2014113404A1 Treating pulmonary conditions
07/24/2014WO2014113358A1 Lyophilization process
07/24/2014WO2014113068A1 Compositions and methods for diagnosing and treating sepsis
07/24/2014WO2014112902A1 Peptide inhibitors of nicotinic acetylcholine receptor
07/24/2014WO2014111811A1 Veterinary supplements
07/24/2014WO2014111458A2 Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases
07/24/2014WO2014111344A1 Cycloalkyne derivatized saccharides
07/24/2014WO2014082042A3 Peptides that stimulate subcutaneous adipogenesis
07/24/2014US20140206750 MODULATION OF APOLIPOPROTEIN (a) EXPRESSION
07/24/2014US20140206636 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
07/24/2014US20140206635 Metal-salen complex compound, local anesthetic and antineoplastic drug
07/24/2014US20140206629 Stromal Derived Factor Inhibition And CXCR4 Blockade
07/24/2014US20140206626 Methods of providing therapeutic effects using cyclosporin components
07/24/2014US20140206623 Treatment of prostate cancer and a method for determining the prognosis for prostate cancer patients
07/24/2014US20140206622 Stable peptide-based pace4 inhibitors
07/24/2014US20140206617 Use of antithrombin in the treatment of pre-eclampsia
07/24/2014US20140206616 Sustained-Release Lipid Pre-Concentrate of Pharmacologically Active Substance And Pharmaceutical Composition Comprising The Same
07/24/2014US20140206615 Glp-1 agonist and cardiovascular complications
07/24/2014US20140206614 Compositions for Achieving a Therapeutic Effect in an Anatomical Structure
07/24/2014US20140206612 Oral insulin therapies and protocol
07/24/2014US20140206611 Long-acting insulin formulations
07/24/2014US20140206610 Preparation Comprising Insulin, Nicotinamide and an Amino Acid
07/24/2014US20140206609 Functionalized Exendin-4 Derivatives
07/24/2014US20140206608 Exendin-4 Derivatives
07/24/2014US20140206601 Methods and Pharmaceutical Compositions for the Treatment of Respiratory Tract Infections
07/24/2014US20140206600 Charged lipoprotein complexes and their uses
07/24/2014US20140206036 Use of proline specific endoproteases to hydrolyse peptides and proteins
07/24/2014US20140205681 HYDROGEN-BOND SURROGATE PEPTIDES AND PEPTIDOMIMETICS FOR p53 REACTIVATION
07/24/2014US20140205675 Horse feed dietary supplement composition derived from chia seed composition
07/24/2014US20140205671 Synthesis and use of polyhydroxyalkanoate (pha) nanocapsules as a protein carrier
07/24/2014US20140205665 Bioresorbable microparticles
07/24/2014US20140205662 System and method for differentially timed local delivery of a combination pharmaceutical preparation for oral therapy
07/24/2014US20140205658 Compositions and methods for treating or preventing radiation- or chemotherapy-induced pulmonary dysfunction
07/24/2014US20140205654 Liposomal vancomycin for the treatment of mrsa infections
07/24/2014US20140205648 Methods for the in situ treatment of bone cancer
07/24/2014US20140205643 Use of alginate oligomers in combating biofilms
07/24/2014US20140205623 Protein-based streptococcus pneumoniae vaccines
07/24/2014US20140205618 Human fertility enhancement with cortisol reduction food
07/24/2014US20140205617 Compositions and Methods for Treatment of Neoplastic Disease
07/24/2014US20140205616 Compositions and methods for the diagnosis and treatment of tumor
07/24/2014US20140205600 Methods of promoting fat loss comprising administering an alk7 inhibitor
07/24/2014US20140205590 Botulinum toxin treatments of neurological and neuropsychiatric disorders
07/24/2014US20140205588 Plasminogen and plasmin variants
07/24/2014US20140205587 Proteases for Degrading Gluten
07/24/2014US20140205584 Anti-tnf-alpha therapy for the mucopolysaccharidoses and other lysosomal disorders
07/24/2014US20140205583 USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY
07/24/2014US20140205581 Formulations containing saccharomyces boulardii and superoxide dismutase (sod) to control obesity
07/24/2014US20140205577 Treatment of Cardiovascular Disorders Using the Cell Differentiation Signaling Protein Nell1
07/24/2014US20140205565 Compositions and Methods for Treating Organ Dysfunction
07/24/2014US20140205564 Hepatitis C Virus Inhibitors
07/24/2014US20140205563 Compositions derived from stem cell released molecules & methods for formulation thereof
07/24/2014US20140205561 Mitigation of cutaneous injury with il-12
07/24/2014US20140205538 Vaccines targeting cellular death receptors
07/24/2014DE102013001151A1 Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit Sprayable liquid formulation for nasal application in particular with increased local residence
07/23/2014EP2757110A1 Novel alpha 1-antitrypsin variant, preparation method thereof, and use thereof
07/23/2014EP2757109A2 HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines
07/23/2014EP2756849A1 Agent for promoting skeletal muscle regeneration
07/23/2014EP2756842A1 Synthesis and use of Polyhydroxyalkanoate (PHA) Nanocapsules as a protein carrier
07/23/2014EP2756077A1 Endoglycosidase from streptococcus pyogenes and methods using it
07/23/2014EP2755993A1 Pseudomonas exotoxin a with less immunogenic b cell epitopes
07/23/2014EP2755687A2 Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof
07/23/2014EP2755676A1 Composition and dressing for wound treatment
07/23/2014EP2755675A2 Glucagon-like peptide-2 compositions and methods of making and using same
07/23/2014EP2755674A1 Antagonists of products of the hs.459642 unigene cluster for the inhibition of proliferation, development or differentiation of stem cells including cancer stem cells
07/23/2014EP2755673A1 Systems and methods for diminishing cell growth and inducing selective killing of target cells
07/23/2014EP2755672A1 Short designed peptides possessing selective actions against bacteria and cancer cells
07/23/2014EP2755671A1 Pterostilbene and statin combination for treatment of metabolic disease, cardiovascular disease, and inflammation
07/23/2014EP2755668A2 Hyr1-derived compositions and methods of treatment using same
07/23/2014EP2755667A2 Method for enhancing the growth and fullness of hair
07/23/2014EP2755633A1 Method of coating microneedle devices
07/23/2014CN1833030B 用于表达、传递及纯化目标多肽的重组载体分子 Expression vectors used in recombinant molecules, and purification of the target polypeptide is passed
07/23/2014CN103946377A 来自化脓性链球菌的内切糖苷酶及其使用方法 From Streptococcus pyogenes within endoglycosidase and method of use
07/23/2014CN103946234A 附加糖链的多肽和含有该多肽的医药组合物 Polypeptides and pharmaceutical compositions containing the oligosaccharide chain polypeptide
07/23/2014CN103946233A 多黏菌素衍生物 Polymyxin derivatives
07/23/2014CN103946232A 抗淀粉样蛋白的ɑ-螺旋阻断超小肽疗法 Anti-amyloid peptide ɑ- ultra-small spiral blocking therapy
07/23/2014CN103945868A 骨生成促进剂 Osteogenesis-promoting agent
07/23/2014CN103945861A 胰高血糖素样肽-2组合物及其制备和使用方法 Glucagon-like peptide-2 compositions and methods for preparing and using
07/23/2014CN103945860A Sall4和其用途 Sall4 and its use
07/23/2014CN103945859A 用于治疗疼痛的方法和组合物 Methods for treating pain and composition
07/23/2014CN103945858A 用于治疗糖尿病和相关病症的方法和组合物 For the treatment of diabetes and related disorders the methods and compositions
07/23/2014CN103945857A 用于治疗代谢疾病、心血管疾病、以及炎症的蝶芪和他汀组合 For the treatment of metabolic disorders, cardiovascular disease, and inflammation pterostilbene and a statin in combination
07/23/2014CN103945856A 用于治疗实体瘤的fap-活化的蛋白酶体抑制剂 Fap- for the treatment of solid tumors, activated proteasome inhibitor
07/23/2014CN103940982A 肿瘤坏死因子-α转化酶的多肽抑制剂的筛选方法及其应用 The screening method of tumor necrosis factor -α-converting enzyme inhibitor peptide and its application
07/23/2014CN103937871A Srrp35基因和表达产物在癌症诊断与治疗中的应用 Srrp35 gene expression products and applications in cancer diagnosis and treatment
07/23/2014CN103937864A 一种从鳀鱼中分离的活性多肽 An isolated from anchovy active polypeptide
07/23/2014CN103937862A 一种具有防治骨质疏松症作用的磷酸化磷虾肽的制备方法 A method for preparing the role of prevention and treatment of osteoporosis phosphorylated peptides having krill
07/23/2014CN103937827A Rna干扰酶及其使用方法 Rna interference enzymes and methods of use
07/23/2014CN103937814A 一种DNA分子及毕赤酵母重组质粒和高效表达耐辐射球菌PprI蛋白的毕赤酵母重组菌 A DNA molecule and recombinant Pichia expression and efficient protein in Deinococcus radiodurans PprI recombinant strain Pichia
07/23/2014CN103937808A 一种重组家蚕素的表达方法及其抗肿瘤应用 A method of expression of recombinant silkworm Its Anti-tumor Applications
07/23/2014CN103937803A 一种纤维胶凝蛋白及其编码基因和应用 A fiber gelling protein and its encoding gene and application
07/23/2014CN103936863A 一种调控stat3磷酸化的融合肽及其应用 A fusion peptide phosphorylated stat3 its Manipulation
07/23/2014CN103936861A 重组草鱼干扰素-白介素1二联蛋白的制备方法及应用 Recombinant interferon grass carp - interleukin 1 bivalent protein preparation and application
07/23/2014CN103936847A Peg-sa及其药物组合物 Peg-sa and pharmaceutical compositions
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 3163